Physician
Imperial Valley Family Care Medical Group Apc
Imperial Valley Family Care Medical Group Apc was paid $9.85M by Medicaid between Jan 2018 and Dec 2024, across 245 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoIMPERIAL VALLEY FAMILY CARE MEDICAL GROUP APC
IMPERIAL, CA 92251
IMPERIAL, CA 92251
33aNPI1275581894assigned 05/05/2006
33bProvider typeGeneral Practice Physician
28Total paid$9.85M
24GClaims640,791
24DCodes billed245
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in California
Rank by total paid#7 of 474
Median peer was paid$10K
This provider vs. median950×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,490 | $966K | |
| 2019 | 86,510 | $1.11M | |
| 2020 | 90,892 | $959K | |
| 2021 | 102,200 | $1.48M | |
| 2022 | 82,544 | $1.33M | |
| 2023 | 135,999 | $1.78M | |
| 2024incomplete | 97,156 | $2.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 102,366 | 91,239 | $2.06M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 80,104 | 70,213 | $1.08M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 11% | 16,600 | 16,461 | $1.07M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4.5% | 4,930 | 4,550 | $447K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 3.2% | 2,355 | 2,329 | $316K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 3.1% | 1,540 | 1,530 | $310K |
| 95811 | 2.6% | 1,236 | 1,232 | $253K | |
| 93015 | 2.0% | 2,351 | 2,307 | $200K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 2.0% | 1,226 | 1,215 | $194K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.9% | 2,380 | 2,340 | $183K |
| 99457 | 1.6% | 14,513 | 14,442 | $162K | |
| 99490 | Ccm add 20min | 1.6% | 60,677 | 60,574 | $161K |
233 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.6% | 3,009 | $157K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.5% | 1,018 | $143K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 3,747 | $129K |
| 93224 | 1.3% | 1,312 | $123K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.2% | 2,551 | $121K |
| J2785 | Injection, regadenoson, 0.1 mg | 1.2% | 1,379 | $119K |
| 99497 | 1.1% | 6,319 | $113K | |
| 10005 | 1.1% | 3,529 | $111K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 2,461 | $105K |
| 97803 | 1.1% | 3,667 | $104K | |
| 99454 | 1.1% | 9,320 | $104K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17,948 | $96K |
| 93000 | <1% | 3,793 | $93K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,516 | $92K |
| 99381 | <1% | 883 | $89K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 4,618 | $85K |
| 90686 | <1% | 6,702 | $75K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 3,527 | $74K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,765 | $71K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,488 | $68K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,066 | $50K |
| 93970 | <1% | 761 | $46K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 5,570 | $45K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 11,171 | $44K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,549 | $44K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 2,607 | $42K |
| 90670 | <1% | 3,966 | $40K | |
| 86580 | <1% | 9,573 | $34K | |
| 93880 | <1% | 705 | $33K | |
| 99173 | <1% | 8,722 | $32K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 5,682 | $30K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,569 | $30K |
| 20611 | <1% | 3,448 | $28K | |
| 90680 | <1% | 2,737 | $27K | |
| 90698 | <1% | 2,473 | $25K | |
| 90710 | <1% | 2,128 | $24K | |
| 99458 | <1% | 2,310 | $23K | |
| 90633 | <1% | 2,158 | $22K | |
| 93923 | <1% | 696 | $22K | |
| 93978 | <1% | 505 | $21K | |
| 83655 | <1% | 1,944 | $21K | |
| 81003 | <1% | 14,074 | $21K | |
| 0001A | <1% | 522 | $21K | |
| 93458 | <1% | 216 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,490 | $19K |
| 95800 | <1% | 160 | $18K | |
| 0002A | <1% | 458 | $18K | |
| 90744 | <1% | 1,738 | $17K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 845 | $16K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,410 | $15K |
| 93925 | <1% | 660 | $15K | |
| 90649 | <1% | 1,048 | $15K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 1,865 | $14K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 842 | $14K |
| 90734 | <1% | 1,262 | $14K | |
| 99223 | Prolong inpt eval add15 m | <1% | 396 | $12K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 2,636 | $12K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 199 | $11K |
| 92551 | <1% | 8,961 | $11K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 167 | $11K |
| 93017 | <1% | 1,923 | $10K | |
| 90700 | <1% | 1,017 | $10K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,279 | $10K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 1,630 | $10K |
| 90648 | <1% | 1,005 | $10K | |
| 90697 | <1% | 598 | $10K | |
| 90696 | <1% | 914 | $10K | |
| 82948 | <1% | 10,978 | $10K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 64 | $9K |
| 95806 | <1% | 149 | $9K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,132 | $8K |
| 90682 | <1% | 182 | $8K | |
| 93296 | <1% | 2,251 | $8K | |
| 93226 | <1% | 1,668 | $8K | |
| 93248 | <1% | 658 | $8K | |
| 90677 | <1% | 207 | $7K | |
| 90715 | <1% | 680 | $7K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 5,014 | $7K |
| 90961 | <1% | 388 | $7K | |
| 93245 | <1% | 19 | $6K | |
| 91200 | <1% | 386 | $6K | |
| 90620 | <1% | 558 | $6K | |
| 0011A | <1% | 183 | $6K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 184 | $6K |
| 0012A | <1% | 163 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 90 | $6K |
| 93298 | <1% | 578 | $6K | |
| 93016 | <1% | 1,912 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,765 | $5K |
| H0033 | Oral medication administration, direct observation | <1% | 237 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 577 | $5K |
| 92552 | <1% | 358 | $5K | |
| 93246 | <1% | 657 | $5K | |
| 99460 | <1% | 128 | $4K | |
| 90651 | <1% | 389 | $4K | |
| 93294 | <1% | 1,375 | $4K | |
| 64566 | <1% | 419 | $4K | |
| 93295 | <1% | 517 | $4K | |
| 93280 | <1% | 345 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 794 | $4K |
| 93018 | <1% | 1,900 | $4K | |
| 51729 | <1% | 28 | $4K | |
| 99439 | <1% | 999 | $4K | |
| 93297 | <1% | 1,785 | $4K | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 700 | $3K |
| 91320 | <1% | 26 | $3K | |
| 90656 | <1% | 165 | $3K | |
| 93225 | <1% | 1,641 | $3K | |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | <1% | 315 | $3K |
| 85018 | <1% | 14,957 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 197 | $3K |
| 51798 | <1% | 735 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 40 | $3K |
| 93227 | <1% | 1,681 | $3K | |
| 90657 | <1% | 261 | $2K | |
| 0081A | <1% | 57 | $2K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 231 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 268 | $2K |
| 90662 | <1% | 849 | $2K | |
| 0013A | <1% | 57 | $2K | |
| 82947 | <1% | 8,353 | $2K | |
| 91319 | <1% | 17 | $1K | |
| 76981 | <1% | 13 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 26 | $1K |
| 97802 | <1% | 152 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 454 | $1K |
| 99152 | <1% | 223 | $1K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 160 | $1K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,898 | $1K |
| 0004A | <1% | 25 | $960.00 | |
| 0154A | <1% | 24 | $950.00 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 34 | $948.48 |
| 99453 | <1% | 342 | $946.81 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 27 | $935.82 |
| 95251 | <1% | 26 | $887.88 | |
| 99305 | <1% | 142 | $858.94 | |
| 99336 | <1% | 159 | $851.73 | |
| 0082A | <1% | 20 | $800.00 | |
| 51797 | <1% | 28 | $772.31 | |
| 99493 | <1% | 834 | $760.41 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 120 | $619.04 |
| 51784 | <1% | 30 | $607.99 | |
| 90962 | <1% | 23 | $540.29 | |
| 51741 | <1% | 45 | $521.33 | |
| 82570 | <1% | 1,318 | $488.23 | |
| 82044 | <1% | 1,160 | $445.35 | |
| 93290 | <1% | 38 | $439.92 | |
| 52000 | <1% | 81 | $413.83 | |
| 81002 | <1% | 190 | $401.08 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 173 | $379.00 |
| 90688 | <1% | 15 | $298.90 | |
| 77080 | <1% | 13 | $293.62 | |
| 90674 | <1% | 25 | $276.86 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 12 | $273.61 |
| 93283 | <1% | 12 | $250.35 | |
| 99335 | <1% | 27 | $234.30 | |
| 94010 | <1% | 13 | $222.21 | |
| 87807 | <1% | 23 | $203.69 | |
| 99188 | <1% | 44 | $187.20 | |
| 93228 | <1% | 46 | $171.96 | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 44 | $171.07 |
| 99000 | <1% | 220 | $160.03 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 123 | $115.77 |
| 96127 | <1% | 25 | $108.03 | |
| 94760 | <1% | 211 | $97.87 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 269 | $79.14 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $73.62 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 473 | $68.80 |
| 77086 | <1% | 40 | $64.62 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 27 | $61.89 |
| 94060 | <1% | 18 | $50.35 | |
| 80061 | Lipid panel | <1% | 31 | $45.68 |
| 81025 | <1% | 12 | $35.67 | |
| 99492 | <1% | 112 | $33.77 | |
| 90461 | <1% | 37 | $30.94 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 24 | $29.22 |
| 82607 | <1% | 21 | $26.40 | |
| 82043 | <1% | 51 | $21.90 | |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans | <1% | 342 | $21.76 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 30 | $20.04 |
| 80053 | Comprehensive metabolic panel | <1% | 32 | $18.38 |
| 90694 | <1% | 99 | $11.16 | |
| 99484 | <1% | 63 | $10.07 | |
| 99443 | <1% | 27 | $8.35 | |
| 82042 | <1% | 119 | $3.53 | |
| 3078F | 0% | 2,962 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 3,887 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 11,345 | $0.00 |
| 3725F | 0% | 711 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 69 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 31 | $0.00 |
| 1160F | 0% | 552 | $0.00 | |
| 3077F | 0% | 635 | $0.00 | |
| 3288F | 0% | 290 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 12 | $0.00 |
| 1159F | 0% | 341 | $0.00 | |
| 1158F | 0% | 437 | $0.00 | |
| 3095F | 0% | 95 | $0.00 | |
| 87631 | 0% | 16 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 17 | $0.00 |
| 99091 | 0% | 19 | $0.00 | |
| 90653 | 0% | 14 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 12 | $0.00 |
| 99487 | Ccm add 20min | 0% | 16 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 220 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 4,080 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 1,098 | $0.00 |
| 3008F | 0% | 5,934 | $0.00 | |
| 1170F | 0% | 1,581 | $0.00 | |
| 3044F | 0% | 1,147 | $0.00 | |
| 3074F | 0% | 2,160 | $0.00 | |
| 3075F | 0% | 506 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,032 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 545 | $0.00 |
| 3079F | 0% | 587 | $0.00 | |
| 1126F | 0% | 1,535 | $0.00 | |
| 3080F | 0% | 163 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 53 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 15 | $0.00 |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 28 | $0.00 |
| 1111F | 0% | 29 | $0.00 | |
| 1101F | 0% | 118 | $0.00 | |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 14 | $0.00 |
| 3017F | 0% | 15 | $0.00 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 0% | 27 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 53 | $0.00 |
| 3048F | 0% | 16 | $0.00 | |
| 93922 | 0% | 28 | $0.00 | |
| 3061F | 0% | 29 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 44 | $0.00 |
| 99494 | 0% | 12 | $0.00 | |
| G8430 | Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) | 0% | 16 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPALAKODETI, VACHASPATHI (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Imperial Valley Family Care Medical Group, Apc | Brawley, CA | $1.55M |
| Imperial Valley Family Care Medical Group | Imperial, CA | $946K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.